Precision Biologics to present at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting

Precision Biologics presents new data from ongoing clinical trial combining NEO-201 with pembrolizumab at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, June 1, 2024, Chicago, IL, McCormick Place.